{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:29:11Z","timestamp":1779334151508,"version":"3.51.4"},"reference-count":16,"publisher":"SAGE Publications","issue":"7","license":[{"start":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T00:00:00Z","timestamp":1689465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Drug-induced subacute cutaneous lupus erythematosus (DI-SCLE) has been associated with drugs with different mechanisms of action, including anti-hypertensives, tumour necrosis factor-\u03b1 inhibitors and even some chemotherapy medicines. In the last years, a few reports have been described in patients treated with cyclin-dependent kinase (CDK) 4\/6 inhibitors, palbociclib and abemaciclib.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report<\/jats:title>\n                    <jats:p>Here, we describe a case of DI-SCLE in association with ribociclib and exemestane in a woman diagnosed with metastatic breast cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Management and outcome<\/jats:title>\n                    <jats:p>Topical mometasone was prescribed for two weeks with complete resolution of lesions, also abemaciclib was substituted for ribociclib, and the patient had stable disease with no relapse of DI-SCLE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>To our knowledge, this is the first report of ribociclib-induced SCLE but based on the DI-SCLE reported cases associated others CDK4\/6 inhibitors, the role of this family of drugs in dermatopathology must be further investigated.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10781552231185855","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T01:51:48Z","timestamp":1689558708000},"page":"1793-1796","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Subacute cutaneous lupus erythematosus following ribociclib therapy for metastatic breast cancer"],"prefix":"10.1177","volume":"29","author":[{"given":"Victoria Lucia","family":"Collada S\u00e1nchez","sequence":"first","affiliation":[{"name":"Pharmacy Department, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"\u00c1lvarez Criado","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Martinez Martin","sequence":"additional","affiliation":[{"name":"Oncology Department, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Zamora Au\u00f1on","sequence":"additional","affiliation":[{"name":"Oncology Department, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Espinosa Arranz","sequence":"additional","affiliation":[{"name":"Oncology Department, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ander","family":"Mayor Ibarguren","sequence":"additional","affiliation":[{"name":"Dermatology Department, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Nacher Jimenez","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Herrero Ambrosio","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Hospital Universitario La Paz, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,7,16]]},"reference":[{"key":"bibr1-10781552231185855","doi-asserted-by":"publisher","DOI":"10.1111\/cup.13673"},{"key":"bibr2-10781552231185855","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-020-00906-8"},{"key":"bibr3-10781552231185855","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000522"},{"key":"bibr4-10781552231185855","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01461-2"},{"key":"bibr5-10781552231185855","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00613-0"},{"key":"bibr6-10781552231185855","doi-asserted-by":"publisher","DOI":"10.1177\/1203475417752369"},{"key":"bibr7-10781552231185855","doi-asserted-by":"publisher","DOI":"10.1111\/cup.13673"},{"key":"bibr8-10781552231185855","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.05.028"},{"key":"bibr9-10781552231185855","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154"},{"key":"bibr10-10781552231185855","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1967"},{"key":"bibr11-10781552231185855","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.07.012"},{"key":"bibr12-10781552231185855","first-page":"1011","volume":"56","author":"B\u0103rbulescu AL","year":"2015","journal-title":"Rom J Morphol Embryol"},{"key":"bibr13-10781552231185855","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-3157"},{"key":"bibr14-10781552231185855","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.693104"},{"key":"bibr15-10781552231185855","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S137783"},{"key":"bibr16-10781552231185855","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-785"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552231185855","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10781552231185855","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10781552231185855","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:28:43Z","timestamp":1777688923000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10781552231185855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,16]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1177\/10781552231185855"],"URL":"https:\/\/doi.org\/10.1177\/10781552231185855","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,16]]}}}